All Stories

  1. Transcriptomic Analysis of Extracellular Vesicles in the Search for Novel Plasma and Thrombus Biomarkers of Ischemic Stroke Etiologies
  2. Role of factor XIII in ischemic stroke: a key molecule promoting thrombus stabilization and resistance to lysis
  3. Trimethylamine N-Oxide as a Mediator Linking Peripheral to Central Inflammation: An In Vitro Study
  4. Role of LCN2 in a murine model of hindlimb ischemia and in peripheral artery disease patients, and its potential regulation by miR-138-5P
  5. Loss of the matrix metalloproteinase-10 causes premature features of aging in satellite cells
  6. Photodynamic nasal SARS-CoV-2 decolonization shortens infectivity and influences specific T-Cell responses
  7. Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation
  8. Lipocalin-2 and Calprotectin Potential Prognosis Biomarkers in Peripheral Arterial Disease
  9. CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage
  10. Molecular and Cellular Mechanisms of Delayed Fracture Healing in Mmp10 (Stromelysin 2) Knockout Mice
  11. Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values
  12. The Bone Regeneration Capacity of BMP-2 + MMP-10 Loaded Scaffolds Depends on the Tissue Status
  13. Association of SDF1 and MMP12 with Atherosclerosis and Inflammation: Clinical and Experimental Study
  14. Inner ear drug delivery through a cochlear implant: Pharmacokinetics in a Macaque experimental model
  15. Association of calprotectin with other inflammatory parameters in the prediction of mortality for ischemic stroke
  16. Circulating TIMP-1 is associated with hematoma volume in patients with spontaneous intracranial hemorrhage
  17. A Role for MMP-10 (Matrix Metalloproteinase-10) in Calcific Aortic Valve Stenosis
  18. Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: a prospective cohort study
  19. MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade
  20. Functional and transcriptomic analysis of extracellular vesicles identifies calprotectin as a new prognostic marker in peripheral arterial disease (PAD)
  21. Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease
  22. Galectin-3 as a novel biotarget in cardiovascular alterations associated to development of severe aortic stenosis
  23. High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients
  24. Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients
  25. Análisis de subpoblaciones monocitarias en relación con los factores de riesgo cardiovascular
  26. Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification
  27. Selective increase of cardiomyocyte derived extracellular vesicles after experimental myocardial infarction and functional effects on the endothelium
  28. MMP10 Promotes Efficient Thrombolysis After Ischemic Stroke in Mice with Induced Diabetes
  29. Phenotypic Screening To Discover Novel Chemical Series as Efficient Antihemorrhagic Agents
  30. Combined sustained release of BMP2 and MMP10 accelerates bone formation and mineralization of calvaria critical size defect in mice
  31. Reduced high-density lipoprotein cholesterol: A valuable, independent prognostic marker in peripheral arterial disease
  32. CM352 Reduces Brain Damage and Improves Functional Recovery in a Rat Model of Intracerebral Hemorrhage
  33. New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator
  34. Discovery and Safety Profiling of a Potent Preclinical Candidate, (4-[4-[[(3R)-3-(Hydroxycarbamoyl)-8-azaspiro[4.5]decan-3-yl]sulfonyl]phenoxy]-N-methylbenzamide) (CM-352), for the Prevention and Treatment of Hemorrhage
  35. Association of Sepsis-Related Mortality with Early Increase of TIMP-1/MMP-9 Ratio
  36. Effect of Lutein and Antioxidant Supplementation on VEGF Expression, MMP-2 Activity, and Ultrastructural Alterations in Apolipoprotein E-Deficient Mouse
  37. Synergistic Effect of Thrombin and CD40 Ligand on Endothelial Matrix Metalloproteinase-10 Expression and Microparticle Generation In Vitro and In Vivo
  38. Matrix Metalloproteinase-10 Effectively Reduces Infarct Size in Experimental Stroke by Enhancing Fibrinolysis via a Thrombin-Activatable Fibrinolysis Inhibitor-Mediated Mechanism
  39. Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis
  40. Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease
  41. Stromelysin-2 (MMP-10) deficiency does not affect adipose tissue formation in a mouse model of nutritionally induced obesity
  42. Tissue-specific PAI-1 gene expression and glycosylation pattern in insulin-resistant old rats
  43. Matrix Metalloproteinase-10 Is Upregulated by Thrombin in Endothelial Cells and Increased in Patients With Enhanced Thrombin Generation
  44. Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
  45. Asociación de marcadores inflamatorios y aterosclerosis subclínica en relación con la edad en sujetos sin enfermedad cardiovascular
  46. Antioxidant effects of vitamins C and E, multivitamin-mineral complex and flavonoids in a model of retinal oxidative stress: The ApoE-deficient mouse
  47. Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test
  48. Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli
  49. Egg yolk improves lipid profile, lipid peroxidation and retinal abnormalities in a murine model of genetic hypercholesterolemia
  50. Vulnerable Plaque Versus Vulnerable Patient: Emerging Blood Biomarkers for Risk Stratification
  51. Metaloproteasas, remodelado vascular y syndromes aterotrombóticos
  52. Folic acid and B vitamins improve hyperhomocysteinemia-induced cardiovascular risk profile in renal transplant recipients
  53. Aterosclerosis en las enfermedades inflamatorias
  54. Phagocytic NADPH Oxidase-Dependent Superoxide Production Stimulates Matrix Metalloproteinase-9: Implications for Human Atherosclerosis
  55. Independent association of matrix metalloproteinase-10, cardiovascular risk factors and subclinical atherosclerosis
  56. The 4G/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin
  57. Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors
  58. C-Reactive Protein Induces Matrix Metalloproteinase-1 and -10 in Human Endothelial Cells
  59. Polimorfismo 4G/5G del PAI-1 en el síndrome metabólico
  60. Effects of cryopreservation on the immunogenicity of porcine arterial allografts in early stages of transplant vasculopathy
  61. Monocyte Cyclooxygenase-2 Activity: A New Therapeutic Target for Atherosclerosis?
  62. Fibrinógeno. Vieja proteína hemostática con nueva función: marcador no invasivo de aterosclerosis subclínica
  63. Vitamins C and E Reduce Retinal Oxidative Stress and Nitric Oxide Metabolites and Prevent Ultrastructural Alterations in Porcine Hypercholesterolemia
  64. Vitamins C and E prevent endothelial VEGF and VEGFR-2 overexpression induced by porcine hypercholesterolemic LDL
  65. Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension
  66. Vitamins C and E downregulate vascular VEGF and VEGFR-2 expression in apolipoprotein-E-deficient mice
  67. Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed
  68. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization
  69. Estabilización de la placa de ateroma: un nuevo concepto basado en la biología dinámica de la aterosclerosis
  70. Dietary supplementation with vitamins C and E prevents downregulation of endothelial NOS expression in hypercholesterolemia in vivo and in vitro
  71. Hyperhomocysteinemia in Liver Cirrhosis: Mechanisms and Role in Vascular and Hepatic Fibrosis
  72. Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplasty
  73. Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis
  74. Torasemide Inhibits Angiotensin II Induced Vasoconstriction and Intracellular Calcium Increase in the Aorta of Spontaneously Hypertensive Rats
  75. Cloning of Rat and Human Inducible Penile Nitric Oxide Synthase. Application for Gene Therapy of Erectile Dysfunction1
  76. Cloning of a Novel Neuronal Nitric Oxide Synthase Expressed in Penis and Lower Urinary Tract
  77. Up-regulation of the levels of androgen receptor and its mRNA by androgens in smooth-muscle cells from rat penis